← Leaderboards
Ryan Coulson Hunter
California Institute Of Technology
$4,869,167
Attributed
$5,016,804
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $822.2K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,016,804 · 5
By mechanism
R01$3,992,716 · 2
R00$713,262 · 1
R61$221,456 · 1
K99$89,370 · 1
Top collaborators
- Timothy J. Griffin1 shared
- Pratik D Jagtap1 shared
Most similar at California Institute Of Technology
Same institution · by research overlap
- Kenneth A Farley$4,261,001
- Jess F Adkins$5,442,248
- Victoria J Orphan$1,879,412
- Selva M Marroquin$327,228
- Daniel R Utter$327,228
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBacteriaEnvironmentMicrobialComplexPseudomonas AeruginosaChronicLungCystic Fibrosis AirwayCystic Fibrosis PatientsCystic FibrosisMicrobiomePathogenEcologyCommunitiesInfectionSiteDisease ProgressionMetabolicCoupledBaseIn VivoLinkSputum
Grant awards (15)
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory$600,716
R01 · FY2025 · AI · contact PI
An enabling approach for deep metaproteomic characterization ofmicrobial contributors to tumorigenesis in clinical samples$221,456
R61 · FY2025 · CA
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory$600,715
R01 · FY2024 · AI · contact PI
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory$493,929
R01 · FY2023 · AI · contact PI
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory$206,534
R01 · FY2023 · AI · contact PI
Bacterial mucin degradation in cystic fibrosis airway disease.$446,311
R01 · FY2021 · HL · contact PI
Bacterial mucin degradation in cystic fibrosis airway disease.$446,311
R01 · FY2020 · HL · contact PI
Bacterial mucin degradation in cystic fibrosis airway disease.$383,310
R01 · FY2019 · HL · contact PI
Bacterial mucin degradation in cystic fibrosis airway disease$63,001
R01 · FY2019 · HL · contact PI
Bacterial mucin degradation in cystic fibrosis airway disease.$377,023
R01 · FY2018 · HL · contact PI
Bacterial mucin degradation in cystic fibrosis airway disease.$374,866
R01 · FY2017 · HL · contact PI
Spatial characterization of microbial communities in the cystic fibrosis lung$236,509
R00 · FY2015 · HL · contact PI
Spatial characterization of microbial communities in the cystic fibrosis lung$239,708
R00 · FY2014 · HL · contact PI
Spatial characterization of microbial communities in the cystic fibrosis lung$237,045
R00 · FY2013 · HL · contact PI
Spatial characterization of microbial communities in the cystic fibrosis lung$89,370
K99 · FY2012 · HL · contact PI